Showing results (31-40 of 100) with videos related to
Sort By:
Pageof 10
American Heart Journal|September 26, 2006
Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trialsSimon de Denus, Jean-Claude Tardif, Michel White, et al.Journal of Cardiac Failure|June 10, 2006
Temporal increases in subclinical levels of inflammation are associated with adverse clinical outcomes in patients with left ventricular dysfunctionSimon De Denus, Michel White, Jean-Claude Tardif, et al.The Canadian Journal of Cardiology|January 23, 2008
Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVDSimon de Denus, Jean-Claude Tardif, Michel White, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 23, 2014
Long-term evolution, secular trends, and risk factors of renal dysfunction following cardiac transplantationKim Lachance, Michel White, Michel Carrier, et al.Pharmacotherapy|July 29, 2008
Key articles and guidelines in the management of hypertension: 2008 updateSarah M Gaffney, Simon de Denus, Kari L Olson, et al.The Annals of Pharmacotherapy|June 14, 2011
Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplastyKim Lachance, Michel Savoie, Maryse Bernard, et al.Scientific Reports|February 3, 2022
Construction of a femininity score in the UK Biobank and its association with angina diagnosis prior to myocardial infarctionAnna Levinsson, Simon de Denus, Johanna Sandoval, et al.Pharmacogenomics|January 19, 2013
An evaluation of pharmacists' expectations towards pharmacogenomicsSimon de Denus, Nathalie Letarte, Thierry Hurlimann, et al.Pharmacotherapy|November 24, 2019
Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial FibrillationSylvie Perreault, Simon de Denus, Brian White-Guay, et al.European Journal of Clinical Pharmacology|February 14, 2019
Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?Sandra Korol, Michel White, Eileen O'Meara, et al.Pageof 10